Consideration of Clozapine and Gender-Affirming Medical Care for an HIV-Positive Person with Schizophrenia and Fluctuating Gender Identity.
From Harvard Medical School; Massachusetts General Hospital, Boston, MA (Drs. Gerken, Keuroghlian, and Freudenreich); McLean Hospital, Belmont MA (Dr. Gerken); Massachusetts Mental Health Center (Dr. McGahee); Fenway Health, Boston, MA (Dr. Keuroghlian); Lindemann Mental Health Center, Boston, MA (Dr. Freudenreich).
Adrienne T
AT
Gerken
Shunda
S
McGahee
Alex S
AS
Keuroghlian
Oliver
O
Freudenreich
D014150:Antipsychotic Agents / Q000008:administration & dosage*; D003024:Clozapine / Q000008:administration & dosage*; D005783:Gender Identity; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003024:Clozapine